Quartz·2 min read·medium
Moderna is testing its first mRNA Ebola vaccine as the Congo outbreak worsens
✦AI Summary
Moderna has initiated clinical trials for its first mRNA-based Ebola vaccine as cases in the Congo continue to rise. The project is supported by a $50 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI).
The trial, backed by up to $50 million from CEPI, comes as the Congo outbreak surpasses 3,700 confirmed cases and 1,600 deaths
sciencehealthworld
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in